封面
市场调查报告书
商品编码
1427970

2024 年 POC 血糖检测全球市场报告

Point-of-Care Glucose Testing Global Market Report 2024

出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

POC血糖检测市场规模预计在未来几年将显着成长。预计到 2028 年将以 5.3% 的复合年增长率 (CAGR) 增长至 59.9 亿美元。预测期内的成长被认为是由于远端医疗医疗服务的扩展、糖尿病照护中个人化医疗的日益重视、糖尿病管理计划的广泛普及、对葡萄糖检测相关研发的投资增加以及连续检测的引入。预测期内的主要趋势包括穿戴式血糖监测设备的开发、血糖测试中智慧型手机连接的整合、家庭医疗保健环境中就地检验的普及、血糖资料分析中人工智慧的引入,以及预计远端监控将会扩大。

由于糖尿病盛行率不断上升,POC 血糖检测市场预计将成长。糖尿病是一种导致血糖值升高的慢性代谢疾病,随着时间的推移,会对各种器官造成重大风险。 POC 血糖检测是一种广泛使用的技术,可帮助测量住院患者的血糖值,并有助于根据血糖变化做出快速治疗方法决策。特别是,这项技术可以提高治疗效果并改善糖尿病管理。根据美国疾病管制与预防中心(CDC)2022年的统计数据,2021年美国约有3,730万人患有糖尿病,占人口的11.3%。此外,国际糖尿病联盟于2021年11月宣布,全球糖尿病人口将从2030年的6.43亿人(11.3%)增加到2045年的7.83亿人(12.2%)。该报告强调了糖尿病对POC的重大影响血糖检测市场。

人口老化的加剧进一步加速了POC血糖检测市场的成长。随着人口转向老化,老年人口比例增加,POC血糖检测变得越来越重要。这项技术对于老年人,特别是那些糖尿病高风险族群或已经被诊断出患有糖尿病的人来说,具有重要意义。世界卫生组织预测,到 2030 年,全球六分之一的人将超过 60 岁。 60岁及以上人口比例预计将从2020年的10亿增加到14亿,到2050年,全球60岁及以上人口预计将翻一番,达到21亿。因此,人口老化的加剧是POC血糖检测市场的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长,2023-2028、2033

第六章市场区隔

  • 全球POC血糖检测市场,依产品、效能及预测细分,2018-2023、2023-2028、2033
  • 刺血针和采血装置
  • 仪表
  • 全球POC血糖测试市场,依测试地点细分,实际与预测,2018-2023年、2023-2028年、2033年
  • 指尖
  • 替代站点测试
  • 全球POC血糖检测市场,依应用细分、实际及预测,2018-2023年、2023-2028年、2033年
  • 1型糖尿病
  • 2型糖尿病
  • 全球POC血糖测试市场,按最终用户细分,实际和预测,2018-2023年、2023-2028年、2033年
  • 专业诊断中心
  • 医院和诊所
  • 居家照护环境
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球POC血糖检测市场,按地区、绩效及预测,2018-2023年、2023-2028年、2033年
  • 全球POC血糖检测市场,依国家、实际及预测,2018-2023年、2023-2028年、2033年

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • POC血糖检测市场竞争形势
  • POC血糖检测市场公司概况
    • F Hoffmann-La Roche Ltd.
    • Abbott Laboratories Inc.
    • Danaher Corporation
    • Siemens Healthineers
    • Becton, Dickinson and Company

第31章 其他大型创新公司

  • TaiDoc Technology Corporation
  • B. Braun Melsungen AG
  • Beckman Coulter Inc.
  • Nipro Corporation
  • Dexcom Inc.
  • Bio-Rad Laboratories Inc.
  • LifeScan Inc.
  • Nova Biomedical Corporation
  • Ypsomed AG
  • Ascensia Diabetes Care Holdings AG
  • Trividia Health Inc.
  • Radiometer Medical ApS
  • HemoCue AB
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13814

Point-of-care glucose testing denotes a quality-assured pathology service administered in close proximity to the patient rather than within the conventional confines of a clinical laboratory. Clinicians or individuals employ small handheld units or glucose analyzers, along with testing strips, for glucose testing on whole blood. This approach reduces the duration from specimen collection to result verification, leading to swifter therapeutic intervention, diminished preanalytical errors, and enhanced patient care.

The primary components in point-of-care glucose testing encompass lancet and lancing devices, strips, and meters. Lancets, small sharp instruments, puncture the skin to extract a small blood drop for testing, while lancing devices securely hold the lancet and are activated with a simple button push. These devices facilitate straightforward blood withdrawal and assessment of blood glucose levels using a blood glucose monitor and test strips in point-of-care glucose testing. Testing sites include fingertips and alternate site testing, applied in both type-1 and type-2 diabetes. Various end-users, such as professional diagnostic centers, hospitals and clinics, home care settings, among others, utilize these methods.

The point-of-care glucose testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care glucose testing market statistics, including point-of-care glucose testing industry global market size, regional shares, competitors with a point-of-care glucose testing market share, detailed point-of-care glucose testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care glucose testing industry. This point-of-care glucose testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care glucose testing market size has grown strongly in recent years. It will grow from $4.63 billion in 2023 to $4.88 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The growth observed in the historical period can be credited to the increasing prevalence of diabetes, heightened awareness of diabetes management, the expansion of the aging population, the augmentation of healthcare infrastructure, and the adoption of point-of-care testing.

The point-of-care glucose testing market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be ascribed to the expansion of telemedicine services, an increasing emphasis on personalized medicine in diabetes care, the proliferation of diabetes management programs, heightened investment in research and development related to glucose testing, and the adoption of continuous glucose monitoring. Key trends expected in the forecast period encompass the development of wearable glucose monitoring devices, the integration of smartphone connectivity in glucose testing, the proliferation of point-of-care testing in home healthcare settings, the adoption of artificial intelligence in glucose data analysis, and the expansion of remote patient monitoring for diabetes.

The point-of-care glucose testing market is anticipated to experience growth, driven by the increasing prevalence of diabetes. Diabetes, a chronic metabolic disorder elevating blood glucose levels, poses severe risks to various organs over time. Point-of-care glucose testing, a widely used technology, aids in determining glucose levels in hospitalized patients, facilitating prompt treatment decisions in response to glycemic changes. Notably, this technology enhances therapeutic outcomes and improves diabetes management. Statistics from 2022 by the Centers for Disease Control and Prevention (CDC) revealed that around 37.3 million people had diabetes in the United States in 2021, constituting 11.3% of the population. Additionally, projections from the International Diabetes Federation in November 2021 forecasted a global diabetic population increase from 643 million (11.3%) in 2030 to 783 million (12.2%) by 2045, underscoring the significant impact of diabetes on the point-of-care glucose testing market.

The growth of the point-of-care glucose testing market is further fueled by the rising aging population. As demographics shift toward an aging population, characterized by an increasing proportion of elderly individuals, point-of-care glucose testing becomes increasingly crucial. This technology serves essential purposes for older individuals, particularly those at higher risk of diabetes or already diagnosed. The World Health Organization projected that by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion, and by 2050, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion. Therefore, the growing aging population is a significant driver of the point-of-care glucose testing market.

Product innovation is a key trend gaining traction in the point-of-care glucose testing market, with major companies focused on developing innovative products. For instance, F. Hoffmann-La Roche AG introduced Cobas Pulse in January 2022, a new point-of-care blood glucose monitor designed for healthcare staff. This handheld device includes an automated glucose test strip reader, camera, and touchscreen, housed in a rugged casing that can be disinfected and used across all age groups, including newborns and intensive care patients. The innovation aims to enhance physicians' workflow by integrating Glucommander dosage software and offering downloadable decision-support apps.

Major companies in the point-of-care glucose testing market are also directing their efforts towards developing advanced solutions such as glucose-ketone monitoring sensors. Abbott Laboratories announced in June 2022 the development of a first-of-its-kind biowearable sensor system that continuously monitors glucose and ketones in diabetic patients. This breakthrough device, granted FDA designation, represents a significant advancement in regulatory status and is set to become the most compact and slender monitoring device globally. It integrates seamlessly with Abbott's digital ecosystem, allowing remote monitoring by healthcare professionals.

In November 2021, Johnson & Johnson acquired Inverness Medical Technology for $1.3 billion, aiming to strengthen its product portfolio in glucose testing. Inverness Medical Technology, a medical device company, brought valuable resources and a robust pipeline of blood glucose meters and test strips to enhance Johnson & Johnson's competitive position in the point-of-care glucose testing market.

Major companies operating in the point-of-care glucose testing market report are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings PLC, Trinity Biotech PLC, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Bluedrop Medical Limited

North America was the largest region in the point of care glucose testing market in 2023. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care glucose testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care glucose testing market consists of revenues earned by entities by providing services such as diagnosis, monitoring, screening, and testing regimes to offer enhanced therapeutic intervention and patient care in lesser time. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care glucose testing market also includes sales of rapid assay dipsticks, glucose monitoring kits, and multifunctional benchtop devices which are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care Glucose Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care glucose testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care glucose testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care glucose testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Lancet And Lancing Devices; Strips; Meters
  • 2) By Testing Site: Fingertips; Alternate Site Testing
  • 3) By Applications: Type-1 Diabetes; Type-2 Diabetes
  • 4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Danaher Corporation; Siemens Healthineers; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care Glucose Testing Market Characteristics

3. Point-of-Care Glucose Testing Market Trends And Strategies

4. Point-of-Care Glucose Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Point-of-Care Glucose Testing Market Size and Growth

  • 5.1. Global Point-of-Care Glucose Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Point-of-Care Glucose Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Point-of-Care Glucose Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Point-of-Care Glucose Testing Market Segmentation

  • 6.1. Global Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lancet And Lancing Devices
  • Strips
  • Meters
  • 6.2. Global Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fingertips
  • Alternate Site Testing
  • 6.3. Global Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Type-1 Diabetes
  • Type-2 Diabetes
  • 6.4. Global Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Professional Diagnostic Centers
  • Hospitals And Clinics
  • Home Care Settings
  • Other End Users

7. Point-of-Care Glucose Testing Market Regional And Country Analysis

  • 7.1. Global Point-of-Care Glucose Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Point-of-Care Glucose Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Point-of-Care Glucose Testing Market

  • 8.1. Asia-Pacific Point-of-Care Glucose Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Point-of-Care Glucose Testing Market

  • 9.1. China Point-of-Care Glucose Testing Market Overview
  • 9.2. China Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Point-of-Care Glucose Testing Market

  • 10.1. India Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Point-of-Care Glucose Testing Market

  • 11.1. Japan Point-of-Care Glucose Testing Market Overview
  • 11.2. Japan Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Point-of-Care Glucose Testing Market

  • 12.1. Australia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Point-of-Care Glucose Testing Market

  • 13.1. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Point-of-Care Glucose Testing Market

  • 14.1. South Korea Point-of-Care Glucose Testing Market Overview
  • 14.2. South Korea Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Point-of-Care Glucose Testing Market

  • 15.1. Western Europe Point-of-Care Glucose Testing Market Overview
  • 15.2. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Point-of-Care Glucose Testing Market

  • 16.1. UK Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Point-of-Care Glucose Testing Market

  • 17.1. Germany Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Point-of-Care Glucose Testing Market

  • 18.1. France Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Point-of-Care Glucose Testing Market

  • 19.1. Italy Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Point-of-Care Glucose Testing Market

  • 20.1. Spain Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Point-of-Care Glucose Testing Market

  • 21.1. Eastern Europe Point-of-Care Glucose Testing Market Overview
  • 21.2. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Point-of-Care Glucose Testing Market

  • 22.1. Russia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Point-of-Care Glucose Testing Market

  • 23.1. North America Point-of-Care Glucose Testing Market Overview
  • 23.2. North America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Point-of-Care Glucose Testing Market

  • 24.1. USA Point-of-Care Glucose Testing Market Overview
  • 24.2. USA Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Point-of-Care Glucose Testing Market

  • 25.1. Canada Point-of-Care Glucose Testing Market Overview
  • 25.2. Canada Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Point-of-Care Glucose Testing Market

  • 26.1. South America Point-of-Care Glucose Testing Market Overview
  • 26.2. South America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Point-of-Care Glucose Testing Market

  • 27.1. Brazil Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Point-of-Care Glucose Testing Market

  • 28.1. Middle East Point-of-Care Glucose Testing Market Overview
  • 28.2. Middle East Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Point-of-Care Glucose Testing Market

  • 29.1. Africa Point-of-Care Glucose Testing Market Overview
  • 29.2. Africa Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Point-of-Care Glucose Testing Market Competitive Landscape And Company Profiles

  • 30.1. Point-of-Care Glucose Testing Market Competitive Landscape
  • 30.2. Point-of-Care Glucose Testing Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danaher Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton, Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Point-of-Care Glucose Testing Market Other Major And Innovative Companies

  • 31.1. TaiDoc Technology Corporation
  • 31.2. B. Braun Melsungen AG
  • 31.3. Beckman Coulter Inc.
  • 31.4. Nipro Corporation
  • 31.5. Dexcom Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. LifeScan Inc.
  • 31.8. Nova Biomedical Corporation
  • 31.9. Ypsomed AG
  • 31.10. Ascensia Diabetes Care Holdings AG
  • 31.11. Trividia Health Inc.
  • 31.12. Radiometer Medical ApS
  • 31.13. HemoCue AB
  • 31.14. EKF Diagnostics Holdings plc
  • 31.15. Trinity Biotech plc

32. Global Point-of-Care Glucose Testing Market Competitive Benchmarking

33. Global Point-of-Care Glucose Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Point-of-Care Glucose Testing Market

35. Point-of-Care Glucose Testing Market Future Outlook and Potential Analysis

  • 35.1 Point-of-Care Glucose Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Point-of-Care Glucose Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Point-of-Care Glucose Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer